Bioresearch Monitoring Information System (BMIS) background page with download file.
Similar Posts
Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Drug Shortage Mitigation Efforts
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law on March 27, 2020 to aid response efforts and ease the economic impact of COVID-19.Medication Health Fraud for Specific Diseases and Conditions
FDA has identified condition-specific medication health fraud scams that can pose significant risks to consumers.Natco Pharma Limited – 672564 – 09/25/2025
CGMP/Finished Pharmaceuticals/AdulteratedViva Raw Issues Voluntary Recall of Two Lots of Dog an Cat Foods Due to Salmonella and Listeria Monocytogenes Contamination
August 25, 2025 – Viva Raw LLC, Charlotte, NC is voluntarily recalling two lots of dog and cat foods due to contamination with Salmonella and Listeria monocytogenes. The recall is for Lot 21495 (Viva Ground Beef for Dogs; Viva Beef & Turkey for Puppies) and Lot 21975 (Viva Ground Chicken for Dogs;Pacific International Marketing Recalls Fresh Italian Parsley Because of Possible Health Risk
Salinas, CA (October 28, 2025) – Pacific International Marketing (“Pacific”) is recalling 474 cases of bulk Italian Parsley because it may be contaminated with Salmonella, an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weUpdate on the Safety of Andexxa by AstraZeneca: FDA Safety Communication
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolic
